Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,175 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06521255RecruitingPhase 3
New drug combo vs standard for relapsed DLBCL
This trial tests a new combination of drugs (tafasitamab + lenalidomide + gemcitabine + oxaliplatin) against a standard combination (rituximab + gemcitabine + oxaliplatin) for people with DLBCL that has returned or stopped responding to prior therapy. The goal is to see if the new combination works better.
BeijingAges 18 years+ - NCT06519474Recruiting
Elastic chest wrap for COPD breathing and walking
This study tests if wearing an elastic chest wrap during exercise can help people with COPD breathe better and walk farther. You would do breathing and walking tests with and without the wrap to see if it makes a difference.
HsinchuAges 20 years+ - NCT06520176RecruitingPhase 3
Comparing two stem cell collection methods for multiple myeloma
This study tests two different combinations of medicines to help collect stem cells for a transplant in people newly diagnosed with multiple myeloma. The goal is to see which approach works better and is safer for you.
Dongyang, ZhejiangAges 18–75 - NCT06523582Recruiting
Genetic study of neuroendocrine tumors in Mexican patients
This study aims to find genetic causes of neuroendocrine tumors in Mexican patients. By understanding your DNA, researchers hope to improve diagnosis and treatment for people with these rare conditions.
Mexico City, Mexico CityAges 18 years+ - NCT06521372Recruiting
AI egg sorting for better IVF embryos
This study tests whether an AI tool that sorts fresh mature eggs by their images can help more become usable blastocysts (embryos that can be transferred) and lead to pregnancy during IVF. It is for people doing ICSI with fresh eggs and planning to transfer one blastocyst.
Las Vegas, NevadaAges Any age - NCT03676504RecruitingPhase 1/Phase 2
CAR T cell therapy for relapsed CD19 blood cancers
This trial tests a type of personalized immune treatment (CD19 CAR T cells made from your T cells) for adults (and children with ALL) whose CD19-positive blood cancer has come back or didn’t respond. It may help your immune system recognize and attack cancer cells that still have CD19.
HeidelbergAges 3 years+ - NCT07795502Recruiting
Tracking infections in cancer patients with sepsis
This study watches how infections grow and respond to treatment in cancer patients who may have sepsis. It aims to find better ways to diagnose and monitor sepsis early, which could improve care and outcomes.
Sohag, Sohag GovernorateAges 18 years+ - NCT07792863Recruiting
Leg strength and movement after ACL reconstruction
This study looks at how your leg muscles and movement patterns recover after ACL reconstruction surgery. It aims to understand progress and help improve rehabilitation.
Saint-Maurice, DemandeAges 18 years+ - NCT07794787Recruiting
Predicting kidney problems in liver cirrhosis with fluid buildup
This study aims to create a formula to predict which patients with liver cirrhosis and fluid in the belly might develop kidney issues. It uses routine lab tests to help doctors identify risks early and plan better care.
New Delhi, National Capital Territory of DelhiAges 18–65 - NCT07797309Enrolling by invitation
Privacy drape for vaginal exams
This study tests a special drape that helps keep you covered and private during a vaginal exam. It may make the exam feel more comfortable and respectful.
OsmaniyeAges 18 years+ - NCT07800572RecruitingPhase 2
Study of anisodine for stroke patients after clot removal
This trial tests whether adding anisodine, a medicine that may protect brain cells, helps people recover better after a stroke caused by a blocked large artery in the brain. It is given after a procedure to remove the clot.
AnyangAges 18–80 - NCT07797985RecruitingPhase 1
COPD app check-up for better medication
This study looks at how well the myCOPD app can spot when a patient's current medication isn't working well for their symptoms. If the app finds a possible issue, it may suggest a review with a clinician. This could help you get better symptom control.
Southampton, EnglandAges 18 years+ - NCT07797712Recruiting
Mirror therapy with standard rehab for post-stroke walking
This study tests whether adding mirror therapy to regular walking and leg exercises helps people who have had a stroke walk better and improve leg function. Mirror therapy uses a mirror to create the illusion that the affected leg is moving, which may help rewire the brain.
Quetta, BalochistanAges 40–70 - NCT07799610Recruiting
Medication safety program for older adults
This program helps adults 55 and older learn how to manage their medications safely and confidently. It may be helpful if you take prescription medicines and want to avoid mistakes or side effects.
Buffalo, New YorkAges 55 years+ - NCT07799116RecruitingPhase 1/Phase 2
Car-t cell therapy for refractory lupus nephritis
This trial tests a new treatment called CD19 CAR-T cell therapy for people with severe lupus nephritis (lupus-related kidney inflammation) that hasn't improved with usual treatments. The therapy uses your own immune cells to target and possibly reset the immune system, which may reduce kidney damage and help control the disease.
Badalona, BarcelonaAges 18–65 - NCT07799363Recruiting
Heart imaging test comparison for patients getting a new heart valve
This study compares two heart imaging scans to see if a newer CT scan works as well as an MRI for checking blood flow and heart tissue in people having a heart valve replacement. It may help improve care for patients with aortic stenosis.
Huddinge, Stockholm CountyAges 60 years+ - NCT07794475RecruitingPhase 1/Phase 2
Trimetazidine for diabetic nerve pain
This trial tests whether the drug trimetazidine can improve nerve damage symptoms in people with type 2 diabetes and diabetic neuropathy. It also looks at how the drug affects a substance in the blood called endothelin-1, which may be involved in nerve damage.
CairoAges 18–65 - NCT07795580Recruiting
Walking exercise for lung cancer patients
This study tests whether a gentle walking program can help lung cancer patients feel less tired, sleep better, and improve their quality of life. It also looks at how exercise affects cell health and what helps people stick with exercise.
TaipeiAges 20 years+ - NCT07793916Recruiting
Heart device and tricuspid valve function study
This study looks at how heart devices like pacemakers affect the tricuspid valve over time. It uses ultrasound to check valve function and see if the device causes any problems.
Seoul, SeoulAges 19 years+ - NCT07794098Recruiting
Sexual health support for gynecologic cancer patients
This study tests a mobile app that provides sexual health information and support to women recently diagnosed with gynecologic cancer. It aims to help you manage concerns about intimacy and sexuality during your cancer treatment.
Taoyuan, GuishanAges 20–70 - NCT07794527Recruiting
Nerve blocks to improve recovery after heart bypass surgery
This study tests whether giving multiple nerve blocks (numbing injections near nerves) during off-pump heart bypass surgery can improve your recovery and pain control. It aims to see if these blocks help you feel better and recover faster after surgery.
CairoAges 18–65 - NCT07799974Recruiting
Tracking fatigue and activity in lung cancer
This study follows patients with advanced lung cancer to see how fatigue and physical activity change during treatment. It aims to help improve support for symptoms like tiredness.
Ghent, Oost-VlaanderenAges 18 years+ - NCT07792993Recruiting
Focused radiation boost for intermediate and high-risk prostate cancer
This trial tests whether adding an extra, targeted dose of radiation to the main tumor during standard radiation therapy can better control prostate cancer. It is for patients with intermediate or high-risk prostate cancer that has not spread, and who are eligible for a shorter course of radiation (20 sessions).
Rome, LazioAges 18–99 - NCT07795398RecruitingPhase 4
Stopping aspirin in older adults with stable heart disease
This trial tests whether older adults with stable heart disease can safely stop taking daily aspirin after two years without increasing the risk of heart attack or stroke. It may help reduce the side effects of long-term aspirin use.
CopenhagenAges 65 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,175 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.